Intrinsiqs

Is Phathom Pharmaceuticals, Inc. overvalued?

Phathom Pharmaceuticals, Inc. (PHAT) — key valuation metrics and fundamentals.

No verdict
Price
$9.58
Fair value
Current P/E
Normal P/E
Market cap
$775.0M
Dividend yield
0.0%
Return on equity
25.7%
Sector
Healthcare

See the full interactive analysis →

Fair value compares PHAT's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.